Clinical Trials
2 trialsNCT02489903 2025-03-17
RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)
EpicentRx, Inc.
Phase 2 Completed
NCT00191750 2007-01-26
A Study of Pemetrexed in Small Cell Lung Cancer, Which Has Returned
Eli Lilly and Company
Phase 2 Completed